Selleck Chemicals supplies over 3,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors.
Company WebsiteColivelin (CLN) is a brain-penetrant neuroprotective peptide with potent long-term capacity against Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. Colivelin is an activator of STAT3.
More Information Supplier PageColivelin (CLN) is a brain-penetrant neuroprotective peptide with potent long-term capacity against Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. Colivelin is an activator of STAT3.
More Information Supplier PageColivelin (CLN) is a brain-penetrant neuroprotective peptide with potent long-term capacity against Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. Colivelin is an activator of STAT3.
More Information Supplier PageColtsfoot Extract is extracted from Tussilago farfara, which is used for relieving inflammatory conditions, as well as respiratory and infectious diseases in humans.
More Information Supplier PageColtuximab (Anti-CD19) is humanized IgG1 monoclonal antibody against CD19 with potential antineoplastic activity. MW : 144.7 KD.
More Information Supplier PageColtuximab (Anti-CD19) is humanized IgG1 monoclonal antibody against CD19 with potential antineoplastic activity. MW : 144.7 KD.
More Information Supplier PageColtuximab (Anti-CD19) is humanized IgG1 monoclonal antibody against CD19 with potential antineoplastic activity. MW : 144.7 KD.
More Information Supplier PageColumbianadin (Zosimin, 2-Butenoic acid), a natural coumarin from Angelica decursiva, is known to have various biological activities including calcium-channel blocking activity, cytotoxic activity against various cancer cell lines, analgesic activities, intestinal absorption and transportation, anti-inflammatory and anti-cancer effects.
More Information Supplier PageColumbin, a diterpenoid furanolactone, is a potential anti-inflammatory drug.
More Information Supplier PageColuracetam (BCI-540, MKC-231) is a nootropic belonging to the racetam family of drugs with cognitive enhancing and neuroprotective effects.
More Information Supplier PageCombretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.Phase 3.
More Information Supplier PageCombretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.Phase 3.
More Information Supplier PageCombretum alfredii Hance Extract is extracted from Combretum alfredii Hance.
More Information Supplier PageCommelina Communis Extract is drawed from Commelina Communis, which has anti-inflammatory effects related to suppression of the NF-κB pathway and can be used to treat chronic inflammation.
More Information Supplier PageCommon burreed tuber Extract is extracted from Sparganium stoloni erum,Buch. -Ham., has antioxidant properties.
More Information Supplier PageCompK (compound K), a potent and selective hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) small molecule inhibitor, significantly improves human T-cell functions, with enhanced T-cell receptor avidity to recognize tumor-associated antigens and tumor cytolytic activity by CD8+ T cells.
More Information Supplier PageCompK (compound K), a potent and selective hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) small molecule inhibitor, significantly improves human T-cell functions, with enhanced T-cell receptor avidity to recognize tumor-associated antigens and tumor cytolytic activity by CD8+ T cells.
More Information Supplier Page
Complanatoside A is a flavonol glycoside isolated from Astragalus complanatus and is used as a quality control index for A. complanatus in the 2010 edition of the Chinese Pharmacopoeia.
More Information Supplier Page
Complanatuside, a flavonoid compound isolated from Astragalus complanatus and Lysimachia christinae, has anti-inflammation, lipid-lowering and hepatoprotective effects.
More Information Supplier PageCompound 10w, a substituted pyrazolo [1,5-a] pyrimidine amide derivative, shows good anticancer activity against HeLa cell line, with IC50 of less than 10 µM against HeLa cell.
More Information Supplier PageCompound 11, a non-toxic and selective δ-secretase inhibitor (IC50=0.7 μM, in fluorescence-based assay) that interacts with both the active site and allosteric site of δ-secretase in Co-crystal structure analysis. The IC50 value of the compound 11 towards δ-secretase in Pala cells is 0.8 μM.
More Information Supplier PageCompound 3i (666-15) is a potent and selective inhibitor of CREB-mediated gene transcription (IC50 = 0.081 ± 0.04 μM) and also potently inhibits cancer cell growth without harming normal cells.
More Information Supplier PageCompound 3i (666-15) is a potent and selective inhibitor of CREB-mediated gene transcription (IC50 = 0.081 ± 0.04 μM) and also potently inhibits cancer cell growth without harming normal cells.
More Information Supplier PageCompound 3i (666-15) is a potent and selective inhibitor of CREB-mediated gene transcription (IC50 = 0.081 ± 0.04 μM) and also potently inhibits cancer cell growth without harming normal cells.
More Information Supplier PageCompound 3i (666-15) is a potent and selective inhibitor of CREB-mediated gene transcription (IC50 = 0.081 ± 0.04 μM) and also potently inhibits cancer cell growth without harming normal cells.
More Information Supplier PageCompound 3i (666-15) is a potent and selective inhibitor of CREB-mediated gene transcription (IC50 = 0.081 ± 0.04 μM) and also potently inhibits cancer cell growth without harming normal cells.
More Information Supplier PageCompound 401 is a synthetic inhibitor of DNA-PK(IC50=0.28 μM) and mTOR (IC50=5.3 μM). It has no inhibition on p110α/p85α PI3K (>100 μM) and blocks the phosphorylation of S6 kinase 1 Thr389 and Akt Ser473 in COS7 cells.
More Information Supplier PageCompound W (3,5-Bis(4-nitrophenoxy)benzoic acid) is a 3,3′-diiodothyronine sulfate (3,3′-T2S) cross-reactive material in maternal serum, which can inhibit γ-secretase.
More Information Supplier PageCompstatin binds to complement component C3 and inhibits complement activation with IC50 of 12 μM.
More Information Supplier PageCompstatin binds to complement component C3 and inhibits complement activation with IC50 of 12 μM.
More Information Supplier PageCompstatin binds to complement component C3 and inhibits complement activation with IC50 of 12 μM.
More Information Supplier PageCompstatin binds to complement component C3 and inhibits complement activation with IC50 of 12 μM.
More Information Supplier PageCompstatin binds to complement component C3 and inhibits complement activation with IC50 of 12 μM.
More Information Supplier PageConatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) with a Kd of 1 nM and 0.8 nM for the long form and the short form of DR5, respectively. Conatumumab induces apoptosis via caspase activation. MW : 144.96 KD.
More Information Supplier PageConatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) with a Kd of 1 nM and 0.8 nM for the long form and the short form of DR5, respectively. Conatumumab induces apoptosis via caspase activation. MW : 144.96 KD.
More Information Supplier PageConatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) with a Kd of 1 nM and 0.8 nM for the long form and the short form of DR5, respectively. Conatumumab induces apoptosis via caspase activation. MW : 144.96 KD.
More Information Supplier PageConcanavalin A is a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics.
More Information Supplier PageConcizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
More Information Supplier PageConcizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
More Information Supplier PageConcizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
More Information Supplier PageCongo Red (Direct Red 28) is an indicator dye that is blue-violet at pH 3.0 and red at pH 5.0. It is an acid dye used in testing for hydrochloric acid in gastric contents but has carcinogenic properties.
More Information Supplier PageConiferyl alcohol is an intermediate in biosynthesis of eugenol and of stilbene and coumarin.
More Information Supplier PageConivaptan HCl(YM 087) is an orally active, non-peptide, vasopressin V1A andV2 receptor antagonist, used in the treatment of euvolemic and hypervolemic hyponatremia.
More Information Supplier PageConivaptan HCl(YM 087) is an orally active, non-peptide, vasopressin V1A andV2 receptor antagonist, used in the treatment of euvolemic and hypervolemic hyponatremia.
More Information Supplier PageConoidin A is a covalent inhibitor of peroxiredoxin II with an IC50 of 25.1 mM for recombinant T. gondii enzyme peroxiredoxin II (rTgPrxII).
More Information Supplier Page
